• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎性乳腺癌:早期识别和诊断至关重要。

Inflammatory breast cancer: early recognition and diagnosis is critical.

机构信息

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

出版信息

Am J Obstet Gynecol. 2021 Oct;225(4):392-396. doi: 10.1016/j.ajog.2021.04.217. Epub 2021 Apr 20.

DOI:10.1016/j.ajog.2021.04.217
PMID:33845027
Abstract

Inflammatory breast cancer is a rare and aggressive malignancy that is often initially misdiagnosed because of its similar presentation to more benign breast pathologies such as mastitis, resulting in treatment delays. Presenting symptoms of inflammatory breast cancer include erythema, skin changes such as peau d' orange or nipple inversion, edema, and warmth of the affected breast. The average age at diagnosis is younger than in noninflammatory breast cancer cases. Known risk factors include African American race and obesity. Diagnostic criteria include erythema occupying at least one-third of the breast, edema, peau d' orange, and/or warmth, with or without an underlying mass; a rapid onset of <3 months; and pathologic confirmation of invasive carcinoma. Treatment of inflammatory breast cancer includes trimodal therapy with chemotherapy, surgery, and radiation. An aggressive surgical approach that includes a modified radical mastectomy enhances survival outcomes. Although the outcomes for patients with inflammatory breast cancer are poor compared with those of patients with noninflammatory breast cancer, patients with inflammatory breast cancer who complete trimodal therapy have a favorable locoregional control rate, underscoring the importance of a prompt diagnosis of this serious but treatable disease. Obstetrician-gynecologists and other primary care providers must recognize the signs and symptoms of inflammatory breast cancer to make a timely diagnosis and referral for specialized care.

摘要

炎性乳腺癌是一种罕见且侵袭性强的恶性肿瘤,由于其表现类似于乳腺炎等更良性的乳腺病变,因此常常被误诊,导致治疗延误。炎性乳腺癌的主要症状包括红斑、橘皮样皮肤改变或乳头内陷、水肿和受累乳房发热。诊断时的平均年龄较非炎性乳腺癌年轻。已知的危险因素包括非裔美国人种族和肥胖。诊断标准包括红斑占乳房的至少三分之一,水肿、橘皮样皮肤改变和/或发热,伴或不伴潜在肿块;发病迅速,<3 个月;病理证实为浸润性癌。炎性乳腺癌的治疗包括化疗、手术和放疗的三联疗法。改良根治性乳房切除术等积极的手术方法可提高生存结果。尽管与非炎性乳腺癌患者相比,炎性乳腺癌患者的预后较差,但完成三联疗法的炎性乳腺癌患者具有良好的局部区域控制率,这强调了及时诊断这种严重但可治疗疾病的重要性。妇产科医生和其他初级保健提供者必须认识到炎性乳腺癌的症状和体征,以便及时诊断和转介接受专业治疗。

相似文献

1
Inflammatory breast cancer: early recognition and diagnosis is critical.炎性乳腺癌:早期识别和诊断至关重要。
Am J Obstet Gynecol. 2021 Oct;225(4):392-396. doi: 10.1016/j.ajog.2021.04.217. Epub 2021 Apr 20.
2
Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.炎性乳腺癌的三联疗法:外科医生的视角。
Oncology. 2010;79(1-2):3-12. doi: 10.1159/000318529. Epub 2010 Nov 3.
3
UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.UNICANCER-PEGASE 07 研究:一项评价新辅助剂量密集化疗后接受多西紫杉醇-5FU 方案辅助治疗炎性乳腺癌的随机 III 期临床试验。
Ann Oncol. 2015 Aug;26(8):1692-7. doi: 10.1093/annonc/mdv216. Epub 2015 May 5.
4
Breast cancer subtypes can be a predictor of pathologic complete response and survival in the neoadjuvant setting for T4 noninflammatory breast cancer.在T4非炎性乳腺癌的新辅助治疗中,乳腺癌亚型可以作为病理完全缓解和生存的预测指标。
Acta Chir Belg. 2014 May-Jun;114(3):153-9. doi: 10.1080/00015458.2014.11681001.
5
Delayed Diagnosis of Inflammatory Breast Cancer Presenting as Acute Mastitis in a Patient One Month Postpartum.产后 1 个月时以急性乳腺炎为表现的炎性乳腺癌的延迟诊断。
Am Surg. 2024 Jul;90(7):1925-1927. doi: 10.1177/00031348241241736. Epub 2024 Mar 24.
6
Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.炎性乳腺癌生物亚型对新辅助治疗反应及癌症结局的影响。
Clin Breast Cancer. 2018 Aug;18(4):e501-e506. doi: 10.1016/j.clbc.2017.10.003. Epub 2017 Oct 7.
7
Current Surgical Management of Inflammatory Breast Cancer.炎性乳腺癌的当前外科治疗方法。
Ann Surg Oncol. 2021 Oct;28(10):5461-5467. doi: 10.1245/s10434-021-10522-z. Epub 2021 Aug 3.
8
Inflammatory breast cancer: the disease, the biology, the treatment.炎性乳腺癌:疾病、生物学、治疗。
CA Cancer J Clin. 2010 Nov-Dec;60(6):351-75. doi: 10.3322/caac.20082. Epub 2010 Oct 19.
9
Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.炎性乳腺癌患者采用三联疗法治疗后发生局部区域性失败的风险因素。
Clin Breast Cancer. 2013 Oct;13(5):335-43. doi: 10.1016/j.clbc.2013.04.002. Epub 2013 Jul 10.
10
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.术前全身治疗后残留疾病对炎性乳腺癌患者临床结局的影响。
Ann Surg Oncol. 2017 Sep;24(9):2563-2569. doi: 10.1245/s10434-017-5903-6. Epub 2017 May 30.

引用本文的文献

1
Double trouble, managing bilateral inflammatory breast cancer: a case report.双重难题:双侧炎性乳腺癌的管理——病例报告
Front Oncol. 2025 Aug 20;15:1595513. doi: 10.3389/fonc.2025.1595513. eCollection 2025.
2
High-throughput assay confirmation of a T-cell receptor pre-mRNA fragment as a blood-based inflammatory breast cancer biomarker.T细胞受体前体mRNA片段作为基于血液的炎性乳腺癌生物标志物的高通量检测确认
medRxiv. 2025 Aug 21:2025.08.19.25333925. doi: 10.1101/2025.08.19.25333925.
3
An Unusual Diagnostic Journey of a Spontaneously Resolving Breast Mass: When Rare Entities Cause Concerning Presentations.
一例自发消退乳腺肿块的不寻常诊断历程:罕见情况引发的相关表现
Cureus. 2025 May 27;17(5):e84924. doi: 10.7759/cureus.84924. eCollection 2025 May.
4
Clinicogenomic characterization of inflammatory breast cancer.炎性乳腺癌的临床基因组特征
Clin Cancer Res. 2025 May 16. doi: 10.1158/1078-0432.CCR-24-2081.
5
Pan-immune-inflammation value predicts survival in inflammatory breast cancer patients.全免疫炎症值可预测炎性乳腺癌患者的生存情况。
Exp Biol Med (Maywood). 2025 May 1;250:10493. doi: 10.3389/ebm.2025.10493. eCollection 2025.
6
Successful unconventional precision treatment of inflammatory hormone receptor-positive breast cancer guided by molecular profiling.基于分子图谱指导的炎性激素受体阳性乳腺癌非传统精准治疗成功案例
NPJ Precis Oncol. 2025 Mar 7;9(1):63. doi: 10.1038/s41698-025-00845-5.
7
Analysis of Clinically Symptomatic Patients to Differentiate Inflammatory Breast Cancer from Mastitis in Asian Women.对有临床症状的亚洲女性患者进行分析,以鉴别炎性乳腺癌与乳腺炎。
Life (Basel). 2024 Dec 24;15(1):5. doi: 10.3390/life15010005.
8
The combination of focal breast edema and adjacent vessel sign to assess the behavior of mass-type invasive ductal carcinoma.联合使用乳腺局灶性水肿和相邻血管征来评估肿块型浸润性导管癌的行为。
BMC Med Imaging. 2024 Dec 5;24(1):332. doi: 10.1186/s12880-024-01518-8.
9
Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis.乳腺影像诊断中的误诊:欧洲乳腺影像学会(EUSOBI)的声明文件 - 第2部分:乳腺影像诊断错误的主要原因及欧洲乳腺影像学会为减少误诊提出的建议
Eur Radiol. 2025 May;35(5):2397-2411. doi: 10.1007/s00330-024-11133-4. Epub 2024 Nov 15.
10
Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study.炎性乳腺癌患者的病理完全缓解率和总生存率:一项国家癌症数据库研究。
Ann Surg Oncol. 2024 Nov;31(12):8057-8067. doi: 10.1245/s10434-024-16026-w. Epub 2024 Aug 19.